We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Nektar Therapeutics issued a statement regarding the current status of an ongoing administrative proceeding with Ellen Leznik, former corporate counsel, who left Nektar in February 2005.
Genentech, Inc. and CGI Pharmaceuticals, Inc. announced that they have entered into an exclusive global collaboration agreement to discover, develop, manufacture and commercialize therapeutics for an undisclosed target for the potential treatment of multiple oncology and autoimmune indications.
Altana Pharma, the drugmaking unit of German chemical company Altana AG, said Tuesday that it will lay off about 400 workers over the next three quarters as it reorganizes its operations.
Leslie Norwalk will serve as acting administrator of the Centers for Medicare & Medicaid Services (CMS) effective Oct. 15, outgoing Administrator Mark McClellan announced in a Sept. 25 email to staff.
The overall cholesterol drug market is growing faster than anticipated, with the introduction of generic Zocor not hurting the competition, according to one analyst.
The fact that the newest generation of antipsychotic drugs used to treat schizophrenia is no more effective than earlier, less expensive treatments illustrates the need for a national dialogue about comparative effectiveness between drug classes, an academic says.
Patients should wait until 2010 to take Boniva (ibandronate) because it is a relatively new osteoporosis drug, and no evidence exists to prove Boniva is any more therapeutic than older drugs, Public Citizen writes in a new October posting on its WorstPills.org Web site.